FDA NDC Directory · JSON-LD · Markdown

EMEND

NDC 0006-3061 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameFOSAPREPITANT DIMEGLUMINE
Labeler / ManufacturerMerck Sharp & Dohme LLC
Marketing categoryNew Drug Application (innovator) · App NDA022023
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsFOSAPREPITANT DIMEGLUMINE (150 mg/5mL)
Marketing started20170203
Package count1

External sources

Source: openFDA. Public-domain (CC0).